Jake R Morgan1, Jianing Wang2, Joshua A Barocas3, Jenifer L Jaeger4, Natalie N Durham5, Hermik Babakhanlou-Chase5, Monica Bharel5, Alexander Y Walley6, Benjamin P Linas7. 1. Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA, USA. Electronic address: jakem@bu.edu. 2. Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, MA, USA. 3. Massachusetts General Hospital, Division of Infectious Diseases, Boston, MA, USA; Brigham and Women's Hospital, Division of Infectious Diseases, Boston, MA, USA. 4. Boston Public Health Commission, Boston, MA, USA. 5. Massachusettes Department of Public Health, Boston, MA, USA. 6. Massachusettes Department of Public Health, Boston, MA, USA; Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Boston, MA, USA. 7. Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, MA, USA; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Abstract
BACKGROUND: Inpatient treatment for substance use disorders is a collection of strategies ranging from short term detoxification to longer term residential treatment. How those with opioid use disorder (OUD) navigate this inpatient treatment system after an encounter for detoxification and subsequent risk of opioid-related overdose is not well understood. METHODS: We used a comprehensive Massachusetts database to characterize the movement of people with OUD through inpatient care from 2013 to 2015, identifying admissions to inpatient detoxification, subsequent inpatient care, and opioid overdose while navigating treatment. We measured the person-years accumulated during each transition period to calculate rates of opioid-related overdose, and investigated how overdose differed in select populations. RESULTS: Sixty-one percent of inpatient detoxification admissions resulted in a subsequent inpatient detoxification admission without progressing to further inpatient care. Overall, there were 287 fatal and 7337 non-fatal overdoses. Persons exiting treatment after detoxification had the greatest risk of overdose (17.3 per 100 person-years) compared to those who exited after subsequent inpatient care (ranging from 5.9 to 6.6 overdoses per 100 person-years). Non-Hispanic whites were most at risk for opioid related overdose with 16 overdoses per 100 person-years and non-Hispanic blacks had the lowest risk with 5 overdoses per 100 person-years. CONCLUSIONS: The majority of inpatient detoxification admissions do not progress to further inpatient care. Recurrent inpatient detoxification admission is common, likely signifying relapse. Rather than functioning as the first step to inpatient care, inpatient detoxification might be more effective as a venue for implementing strategies to expand addiction services or treatment such as medications for opioid use disorder.
BACKGROUND: Inpatient treatment for substance use disorders is a collection of strategies ranging from short term detoxification to longer term residential treatment. How those with opioid use disorder (OUD) navigate this inpatient treatment system after an encounter for detoxification and subsequent risk of opioid-related overdose is not well understood. METHODS: We used a comprehensive Massachusetts database to characterize the movement of people with OUD through inpatient care from 2013 to 2015, identifying admissions to inpatient detoxification, subsequent inpatient care, and opioid overdose while navigating treatment. We measured the person-years accumulated during each transition period to calculate rates of opioid-related overdose, and investigated how overdose differed in select populations. RESULTS: Sixty-one percent of inpatient detoxification admissions resulted in a subsequent inpatient detoxification admission without progressing to further inpatient care. Overall, there were 287 fatal and 7337 non-fatal overdoses. Persons exiting treatment after detoxification had the greatest risk of overdose (17.3 per 100 person-years) compared to those who exited after subsequent inpatient care (ranging from 5.9 to 6.6 overdoses per 100 person-years). Non-Hispanic whites were most at risk for opioid related overdose with 16 overdoses per 100 person-years and non-Hispanic blacks had the lowest risk with 5 overdoses per 100 person-years. CONCLUSIONS: The majority of inpatient detoxification admissions do not progress to further inpatient care. Recurrent inpatient detoxification admission is common, likely signifying relapse. Rather than functioning as the first step to inpatient care, inpatient detoxification might be more effective as a venue for implementing strategies to expand addiction services or treatment such as medications for opioid use disorder.
Authors: Alexander Y Walley; Debbie M Cheng; Emily K Quinn; Elena Blokhina; Natalia Gnatienko; Christine E Chaisson; Evgeny Krupitsky; Philip O Coffin; Jeffrey H Samet Journal: Int J Drug Policy Date: 2016-11-28
Authors: James D Wines; Richard Saitz; Nicholas J Horton; Christine Lloyd-Travaglini; Jeffrey H Samet Journal: Drug Alcohol Depend Date: 2007-02-05 Impact factor: 4.492
Authors: Margaret T Lee; Constance M Horgan; Deborah W Garnick; Andrea Acevedo; Lee Panas; Grant A Ritter; Robert Dunigan; Hermik Babakhanlou-Chase; Alfred Bidorini; Kevin Campbell; Karin Haberlin; Alice Huber; Dawn Lambert-Wacey; Tracy Leeper; Mark Reynolds Journal: J Subst Abuse Treat Date: 2014-05-02
Authors: Amity E Quinn; Dominic Hodgkin; Jennifer N Perloff; Maureen T Stewart; Mary Brolin; Nancy Lane; Constance M Horgan Journal: J Subst Abuse Treat Date: 2017-09-21
Authors: Jake R Morgan; Emily K Quinn; Christine E Chaisson; Elizabeth Ciemins; Nikita Stempniewicz; Laura F White; Benjamin P Linas; Alexander Y Walley; Marc R LaRochelle Journal: Med Care Date: 2022-03-01 Impact factor: 3.178
Authors: Alexandra Savinkina; Rajapaksha W M A Madushani; Golnaz Eftekhari Yazdi; Jianing Wang; Joshua A Barocas; Jake R Morgan; Sabrina A Assoumou; Alexander Y Walley; Benjamin P Linas; Sean M Murphy Journal: Addiction Date: 2022-04-12 Impact factor: 7.256
Authors: Jake R Morgan; Joshua A Barocas; Sean M Murphy; Rachel L Epstein; Michael D Stein; Bruce R Schackman; Alexander Y Walley; Benjamin P Linas Journal: JAMA Netw Open Date: 2020-12-01